What’s in a Name? Terminology Preferences Among Patients Receiving Methadone Treatment

Gaeta, Marina; Maclean, Emma; Beitel, Mark; Carmichael, Iain; Cammack, Katharine M; Eggert, Kathryn F.; Roehrich, Teresa; Madden, Lynn M.; Jegede, Oluwole; Zheng, Xiaoying; Bergman, Emma; Barry, Declan T.

doi:10.1007/s11606-022-07813-w

Cited by 4 publications

(1 citation statement)

References 61 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As described previously, 27 between January 1, 2019, and February 28, 2020, consecutive patients completed a survey 1 month after methadone treatment enrollment at the APT Foundation (APT), a not-for-profit, community-based federally licensed opioid treatment provider located in Connecticut. APT Foundation operates a low-barrier treatment model aimed to maximize treatment enrollment by reducing wait time and common treatment barriers 28 .…”

Section: Methodsmentioning

confidence: 99%

A Quantitative Examination of Illness Models Among People With Opioid Use Disorder Receiving Methadone Treatment

Gaeta Gazzola,

Carmichael,

Thompson

et al. 2024

J Addict Med

Self Cite

View full text Add to dashboard Cite

Background Few studies have examined illness models among people with addiction. We investigated illness models and their associations with demographics and treatment beliefs among patients receiving methadone treatment for opioid use disorder. Methods From January 2019 to February 2020, patients receiving methadone treatment at outpatient opioid treatment programs provided demographics and rated using 1 to 7 Likert-type scales agreement with addiction illness models (brain disease model, chronic medical condition model [CMCM], and no explanation [NEM]) and treatment beliefs. Pairwise comparisons and multivariate regressions were used to examine associations between illness models, demographics, and treatment beliefs. Statistical significance was set at P < 0.05. Results A total of 450 patients participated in the study. Forty percent self-identified as female, 13% as Hispanic, and 78% as White; mean age was 38.5 years. Brain disease model was the most frequently endorsed illness model (46.2%), followed by CMCM (41.7%) and NEM (21.9%). In multivariate analyses, agreement with brain disease model was significantly positively associated with beliefs that methadone treatment would be effective, counseling is important, and methadone is lifesaving, whereas agreement with CMCM was significantly positively associated with beliefs that methadone treatment would be effective, counseling is important, 12-step is the best treatment, taking methadone daily is important, and methadone is lifesaving. In multivariate analyses, agreement with NEM was negatively significantly associated with beliefs that methadone would be effective, counseling is important, taking methadone daily is important, and methadone is lifesaving. Discussion Many patients in methadone treatment endorsed medicalized addiction models. Agreement with addiction illness models appear to be related to treatment beliefs.

show abstract

Section: Methodsmentioning

confidence: 99%